John Carroll
Concepts (521)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Body | 26 | 2015 | 43 | 7.220 |
Why?
| Oocytes | 18 | 2025 | 92 | 6.640 |
Why?
| Meiosis | 11 | 2025 | 74 | 2.940 |
Why?
| Chemoreceptor Cells | 14 | 2023 | 23 | 2.880 |
Why?
| Mitochondria | 12 | 2025 | 430 | 2.480 |
Why?
| Potassium Channels, Tandem Pore Domain | 7 | 2015 | 11 | 2.110 |
Why?
| Calcium | 10 | 2025 | 376 | 1.960 |
Why?
| Fertility | 3 | 2025 | 32 | 1.890 |
Why?
| Hyperoxia | 8 | 2023 | 27 | 1.850 |
Why?
| Respiration, Artificial | 10 | 2024 | 308 | 1.520 |
Why?
| Oxygen | 11 | 2024 | 336 | 1.410 |
Why?
| Animals | 52 | 2025 | 13505 | 1.350 |
Why?
| Embryonic Development | 4 | 2025 | 18 | 1.300 |
Why?
| Aortic Valve Stenosis | 8 | 2024 | 76 | 1.260 |
Why?
| Blastocyst | 3 | 2025 | 15 | 1.200 |
Why?
| Cell Nucleus | 2 | 2025 | 187 | 1.060 |
Why?
| Microtubules | 3 | 2025 | 39 | 1.020 |
Why?
| Rats | 19 | 2015 | 3220 | 0.960 |
Why?
| Membrane Potentials | 9 | 2024 | 109 | 0.960 |
Why?
| Cell Hypoxia | 5 | 2013 | 83 | 0.910 |
Why?
| Respiration Disorders | 3 | 2023 | 23 | 0.890 |
Why?
| Animals, Newborn | 15 | 2015 | 362 | 0.880 |
Why?
| Lysosomes | 1 | 2024 | 76 | 0.870 |
Why?
| Mice | 23 | 2025 | 5949 | 0.850 |
Why?
| Actins | 1 | 2023 | 115 | 0.790 |
Why?
| Female | 56 | 2025 | 28171 | 0.780 |
Why?
| Humans | 76 | 2025 | 52483 | 0.740 |
Why?
| Lung Diseases | 3 | 2019 | 88 | 0.730 |
Why?
| Infant, Extremely Premature | 4 | 2024 | 33 | 0.700 |
Why?
| Mitochondrial Diseases | 1 | 2021 | 45 | 0.690 |
Why?
| Nerve Tissue Proteins | 7 | 2015 | 187 | 0.690 |
Why?
| Hydrogen Peroxide | 1 | 2021 | 120 | 0.680 |
Why?
| Foramen Ovale, Patent | 4 | 2025 | 31 | 0.660 |
Why?
| Stroke | 7 | 2025 | 512 | 0.630 |
Why?
| Mitral Valve Annuloplasty | 1 | 2019 | 4 | 0.620 |
Why?
| Kinetochores | 2 | 2022 | 4 | 0.620 |
Why?
| Mitral Valve | 2 | 2019 | 52 | 0.610 |
Why?
| Patch-Clamp Techniques | 7 | 2015 | 111 | 0.610 |
Why?
| Shock, Cardiogenic | 1 | 2019 | 30 | 0.610 |
Why?
| Journal Impact Factor | 1 | 2018 | 8 | 0.600 |
Why?
| Mitral Valve Insufficiency | 1 | 2019 | 52 | 0.590 |
Why?
| Cystic Fibrosis | 3 | 2015 | 154 | 0.580 |
Why?
| DNA, Mitochondrial | 4 | 2024 | 114 | 0.570 |
Why?
| Publishing | 1 | 2018 | 37 | 0.570 |
Why?
| Sleep Apnea Syndromes | 4 | 2023 | 32 | 0.570 |
Why?
| Rats, Sprague-Dawley | 10 | 2015 | 1563 | 0.570 |
Why?
| Cyclin A2 | 1 | 2017 | 2 | 0.570 |
Why?
| Chromosomes, Mammalian | 1 | 2017 | 4 | 0.570 |
Why?
| Home Care Services | 4 | 2023 | 72 | 0.560 |
Why?
| Registries | 10 | 2024 | 581 | 0.560 |
Why?
| Periodicals as Topic | 1 | 2018 | 61 | 0.560 |
Why?
| Orthopedics | 1 | 2018 | 53 | 0.550 |
Why?
| Sleep Apnea, Obstructive | 5 | 2018 | 71 | 0.550 |
Why?
| Adenosine Triphosphate | 3 | 2013 | 205 | 0.530 |
Why?
| Infant, Premature | 7 | 2023 | 333 | 0.530 |
Why?
| Male | 41 | 2025 | 26761 | 0.520 |
Why?
| Tracheostomy | 2 | 2023 | 76 | 0.510 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2015 | 5 | 0.500 |
Why?
| Maternal Age | 1 | 2015 | 45 | 0.490 |
Why?
| Health Personnel | 2 | 2015 | 256 | 0.490 |
Why?
| Hydrogen Sulfide | 1 | 2015 | 6 | 0.480 |
Why?
| DNA Damage | 2 | 2023 | 305 | 0.470 |
Why?
| Transient Receptor Potential Channels | 1 | 2015 | 5 | 0.470 |
Why?
| Fertilization | 2 | 2025 | 7 | 0.470 |
Why?
| Transition to Adult Care | 1 | 2015 | 18 | 0.460 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 82 | 0.460 |
Why?
| Respiratory Therapy | 1 | 2015 | 36 | 0.460 |
Why?
| Pregnancy | 8 | 2025 | 2680 | 0.460 |
Why?
| Mitosis | 2 | 2025 | 88 | 0.460 |
Why?
| Enzyme Inhibitors | 2 | 2014 | 372 | 0.450 |
Why?
| Chromosome Segregation | 2 | 2025 | 13 | 0.450 |
Why?
| Oogenesis | 3 | 2025 | 18 | 0.440 |
Why?
| AMP-Activated Protein Kinases | 1 | 2014 | 31 | 0.440 |
Why?
| Electron Transport Complex IV | 1 | 2013 | 24 | 0.430 |
Why?
| Septal Occluder Device | 4 | 2025 | 36 | 0.420 |
Why?
| Pediatrics | 2 | 2016 | 293 | 0.420 |
Why?
| Piperidines | 3 | 2021 | 97 | 0.420 |
Why?
| Child | 20 | 2020 | 7248 | 0.410 |
Why?
| Sleep | 5 | 2021 | 187 | 0.400 |
Why?
| Staphylococcal Infections | 1 | 2015 | 285 | 0.400 |
Why?
| Clinical Competence | 1 | 2015 | 406 | 0.400 |
Why?
| Time Factors | 9 | 2024 | 2968 | 0.390 |
Why?
| Neural Conduction | 3 | 2009 | 34 | 0.390 |
Why?
| Analysis of Variance | 6 | 2015 | 554 | 0.380 |
Why?
| Bronchopulmonary Dysplasia | 3 | 2023 | 81 | 0.370 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 509 | 0.370 |
Why?
| Potassium Channels, Inwardly Rectifying | 1 | 2011 | 7 | 0.360 |
Why?
| Aortic Valve | 7 | 2024 | 123 | 0.360 |
Why?
| Infant, Newborn | 14 | 2024 | 2867 | 0.360 |
Why?
| Osteogenesis Imperfecta | 2 | 2022 | 37 | 0.360 |
Why?
| Infant | 16 | 2024 | 3733 | 0.360 |
Why?
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 12 | 0.360 |
Why?
| Collagen Type I | 2 | 2022 | 83 | 0.350 |
Why?
| Pulmonary Ventilation | 1 | 2010 | 12 | 0.350 |
Why?
| Mice, Knockout | 3 | 2025 | 879 | 0.340 |
Why?
| Mechanotransduction, Cellular | 1 | 2011 | 42 | 0.340 |
Why?
| Signal Transduction | 3 | 2025 | 1671 | 0.340 |
Why?
| Cardiac Catheterization | 3 | 2025 | 232 | 0.340 |
Why?
| Aging | 3 | 2004 | 701 | 0.340 |
Why?
| Risk Factors | 14 | 2024 | 3889 | 0.340 |
Why?
| Prometaphase | 1 | 2009 | 1 | 0.330 |
Why?
| Meiotic Prophase I | 1 | 2009 | 1 | 0.330 |
Why?
| United States | 14 | 2024 | 5192 | 0.330 |
Why?
| Dynamins | 3 | 2025 | 9 | 0.310 |
Why?
| Treatment Outcome | 13 | 2025 | 5422 | 0.310 |
Why?
| Zygote | 2 | 2025 | 10 | 0.310 |
Why?
| Respiration | 6 | 2024 | 101 | 0.300 |
Why?
| Infant, Premature, Diseases | 3 | 2024 | 94 | 0.290 |
Why?
| Receptors, Dopamine D2 | 2 | 2005 | 17 | 0.290 |
Why?
| Apnea | 2 | 2024 | 18 | 0.270 |
Why?
| Bradycardia | 2 | 2024 | 38 | 0.270 |
Why?
| Neurotransmitter Agents | 2 | 2009 | 34 | 0.270 |
Why?
| Aged | 11 | 2023 | 10121 | 0.260 |
Why?
| Chronic Disease | 5 | 2019 | 586 | 0.260 |
Why?
| Medicare | 3 | 2023 | 274 | 0.260 |
Why?
| Cyclin B1 | 2 | 2020 | 7 | 0.260 |
Why?
| Sleep Stages | 3 | 2011 | 40 | 0.250 |
Why?
| Age Factors | 6 | 2019 | 1132 | 0.250 |
Why?
| Delivery of Health Care | 2 | 2019 | 323 | 0.250 |
Why?
| Risk Assessment | 5 | 2021 | 1327 | 0.250 |
Why?
| Polysomnography | 8 | 2015 | 73 | 0.250 |
Why?
| Parthenogenesis | 1 | 2025 | 3 | 0.240 |
Why?
| Metalloproteases | 1 | 2025 | 10 | 0.240 |
Why?
| Hospitals, Pediatric | 3 | 2015 | 243 | 0.240 |
Why?
| Patient Discharge | 2 | 2019 | 330 | 0.240 |
Why?
| Cells, Cultured | 5 | 2020 | 1567 | 0.240 |
Why?
| Continuous Positive Airway Pressure | 2 | 2018 | 65 | 0.240 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 17 | 0.240 |
Why?
| Telomere Homeostasis | 1 | 2025 | 11 | 0.240 |
Why?
| Embryo, Mammalian | 1 | 2025 | 67 | 0.240 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2025 | 17 | 0.240 |
Why?
| Telomere | 1 | 2025 | 38 | 0.230 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2004 | 12 | 0.230 |
Why?
| Retrospective Studies | 10 | 2024 | 6607 | 0.230 |
Why?
| Potassium | 1 | 2004 | 58 | 0.230 |
Why?
| Ovum | 1 | 2024 | 7 | 0.230 |
Why?
| Infant Equipment | 1 | 2024 | 4 | 0.230 |
Why?
| Posture | 2 | 2024 | 66 | 0.220 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2025 | 151 | 0.220 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 421 | 0.210 |
Why?
| DNA Copy Number Variations | 1 | 2024 | 117 | 0.210 |
Why?
| Pyridines | 1 | 2004 | 132 | 0.210 |
Why?
| Aged, 80 and over | 7 | 2021 | 3392 | 0.210 |
Why?
| Movement | 2 | 2021 | 82 | 0.210 |
Why?
| Oximes | 2 | 2021 | 16 | 0.210 |
Why?
| Sleep Apnea, Central | 1 | 2003 | 12 | 0.210 |
Why?
| Polymerization | 1 | 2023 | 4 | 0.210 |
Why?
| Respiratory Muscles | 1 | 2003 | 5 | 0.210 |
Why?
| Parents | 3 | 2021 | 335 | 0.200 |
Why?
| Respiratory System | 1 | 2003 | 28 | 0.200 |
Why?
| Heart Rate | 1 | 2024 | 318 | 0.200 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2022 | 48 | 0.200 |
Why?
| Neuronal Plasticity | 1 | 2003 | 45 | 0.200 |
Why?
| Ehlers-Danlos Syndrome | 1 | 2022 | 8 | 0.190 |
Why?
| RNA, Messenger | 5 | 2020 | 1132 | 0.190 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2021 | 137 | 0.190 |
Why?
| Cytoplasm | 1 | 2022 | 94 | 0.190 |
Why?
| Heart Valve Prosthesis Implantation | 2 | 2021 | 96 | 0.190 |
Why?
| Cardiology | 1 | 2023 | 97 | 0.190 |
Why?
| Ovary | 1 | 2022 | 107 | 0.190 |
Why?
| Longevity | 1 | 2022 | 85 | 0.190 |
Why?
| Infertility, Female | 1 | 2021 | 19 | 0.190 |
Why?
| Methyltransferases | 1 | 2021 | 29 | 0.190 |
Why?
| Intracellular Space | 2 | 2014 | 26 | 0.190 |
Why?
| Catecholamines | 2 | 2013 | 44 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 3 | 2015 | 1378 | 0.190 |
Why?
| Multicenter Studies as Topic | 4 | 2023 | 105 | 0.180 |
Why?
| Decompression Sickness | 1 | 2021 | 1 | 0.180 |
Why?
| In Vitro Oocyte Maturation Techniques | 1 | 2021 | 3 | 0.180 |
Why?
| RNA, Small Interfering | 1 | 2021 | 213 | 0.180 |
Why?
| Sepsis | 1 | 2024 | 239 | 0.180 |
Why?
| Australia | 1 | 2021 | 89 | 0.180 |
Why?
| Migraine Disorders | 1 | 2021 | 47 | 0.170 |
Why?
| Mice, Inbred C57BL | 4 | 2025 | 1884 | 0.170 |
Why?
| Histones | 1 | 2022 | 314 | 0.170 |
Why?
| Thromboembolism | 1 | 2021 | 52 | 0.170 |
Why?
| Electrophysiology | 2 | 2011 | 68 | 0.170 |
Why?
| Ventilators, Mechanical | 1 | 2020 | 43 | 0.160 |
Why?
| Coenzyme A | 1 | 2019 | 9 | 0.160 |
Why?
| RNA-Binding Proteins | 1 | 2020 | 128 | 0.160 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.160 |
Why?
| Respiratory Mechanics | 2 | 2018 | 41 | 0.160 |
Why?
| Molecular Chaperones | 1 | 2020 | 66 | 0.160 |
Why?
| Action Potentials | 2 | 2013 | 120 | 0.160 |
Why?
| Adolescent | 11 | 2018 | 6739 | 0.160 |
Why?
| Obesity | 3 | 2022 | 1162 | 0.160 |
Why?
| Tertiary Care Centers | 2 | 2018 | 85 | 0.160 |
Why?
| Colorado | 1 | 2019 | 25 | 0.160 |
Why?
| Nitric Oxide | 2 | 2011 | 249 | 0.150 |
Why?
| Disease Management | 2 | 2021 | 188 | 0.150 |
Why?
| Plethysmography | 1 | 2018 | 43 | 0.150 |
Why?
| Disease Models, Animal | 4 | 2022 | 1478 | 0.150 |
Why?
| Protein Biosynthesis | 1 | 2020 | 258 | 0.150 |
Why?
| Atrial Fibrillation | 2 | 2018 | 200 | 0.150 |
Why?
| Length of Stay | 2 | 2019 | 663 | 0.150 |
Why?
| Ion Channel Gating | 2 | 2011 | 33 | 0.150 |
Why?
| Child, Preschool | 8 | 2018 | 4076 | 0.150 |
Why?
| DNA Methylation | 1 | 2022 | 592 | 0.150 |
Why?
| Supine Position | 3 | 2024 | 28 | 0.150 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2015 | 39 | 0.150 |
Why?
| Prone Position | 3 | 2024 | 32 | 0.150 |
Why?
| Databases, Factual | 2 | 2019 | 706 | 0.140 |
Why?
| Recovery of Function | 1 | 2019 | 199 | 0.140 |
Why?
| Spirometry | 1 | 2018 | 33 | 0.140 |
Why?
| Secondary Prevention | 1 | 2018 | 84 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 582 | 0.140 |
Why?
| Hemodynamics | 1 | 2019 | 263 | 0.140 |
Why?
| KCNQ2 Potassium Channel | 1 | 2017 | 9 | 0.140 |
Why?
| Myoclonus | 1 | 2017 | 9 | 0.130 |
Why?
| Phosphorylation | 2 | 2019 | 528 | 0.130 |
Why?
| Spasms, Infantile | 1 | 2017 | 30 | 0.130 |
Why?
| Prospective Studies | 5 | 2024 | 2481 | 0.130 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2017 | 505 | 0.130 |
Why?
| bcl-2-Associated X Protein | 1 | 2016 | 58 | 0.130 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 21 | 0.130 |
Why?
| Hospitals, Special | 1 | 2016 | 9 | 0.130 |
Why?
| Epitopes | 1 | 2016 | 65 | 0.130 |
Why?
| Molecular Typing | 1 | 2015 | 11 | 0.130 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 28 | 0.130 |
Why?
| Metaphase | 1 | 2015 | 46 | 0.120 |
Why?
| Patient Care Team | 2 | 2015 | 272 | 0.120 |
Why?
| Arteries | 2 | 2009 | 92 | 0.120 |
Why?
| Cell Cycle Proteins | 2 | 2022 | 169 | 0.120 |
Why?
| Manikins | 1 | 2015 | 35 | 0.120 |
Why?
| Pseudomonas Infections | 1 | 2015 | 54 | 0.120 |
Why?
| Pancreaticoduodenectomy | 1 | 2015 | 12 | 0.120 |
Why?
| Alkynes | 1 | 2015 | 6 | 0.120 |
Why?
| Intracellular Fluid | 1 | 2015 | 11 | 0.120 |
Why?
| Pseudomonas aeruginosa | 1 | 2015 | 78 | 0.120 |
Why?
| Sodium Compounds | 1 | 2015 | 10 | 0.120 |
Why?
| Cardiac Surgical Procedures | 1 | 2018 | 321 | 0.120 |
Why?
| Hospital Charges | 1 | 2015 | 46 | 0.120 |
Why?
| DNA, Bacterial | 1 | 2015 | 176 | 0.120 |
Why?
| Coinfection | 1 | 2015 | 47 | 0.120 |
Why?
| Patient Safety | 1 | 2015 | 104 | 0.120 |
Why?
| Boron Compounds | 1 | 2015 | 19 | 0.120 |
Why?
| NAD | 1 | 2015 | 45 | 0.120 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 40 | 0.120 |
Why?
| RNA | 2 | 2006 | 168 | 0.120 |
Why?
| Glycine | 1 | 2015 | 75 | 0.120 |
Why?
| Sequence Alignment | 1 | 2015 | 125 | 0.120 |
Why?
| Computer Simulation | 1 | 2015 | 290 | 0.120 |
Why?
| Embolism, Paradoxical | 1 | 2014 | 4 | 0.110 |
Why?
| Mutation | 3 | 2022 | 1347 | 0.110 |
Why?
| Databases, Genetic | 1 | 2015 | 83 | 0.110 |
Why?
| Tacrolimus | 1 | 2015 | 59 | 0.110 |
Why?
| Polymerase Chain Reaction | 1 | 2015 | 461 | 0.110 |
Why?
| Foreign Bodies | 1 | 2015 | 66 | 0.110 |
Why?
| Aminoimidazole Carboxamide | 1 | 2014 | 2 | 0.110 |
Why?
| Ribonucleotides | 1 | 2014 | 4 | 0.110 |
Why?
| Pyrones | 1 | 2014 | 8 | 0.110 |
Why?
| Genotype | 1 | 2015 | 566 | 0.110 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.110 |
Why?
| PC12 Cells | 1 | 2014 | 25 | 0.110 |
Why?
| Reference Values | 3 | 2011 | 313 | 0.110 |
Why?
| Biphenyl Compounds | 1 | 2014 | 31 | 0.110 |
Why?
| Oxidative Stress | 3 | 2024 | 807 | 0.110 |
Why?
| Sodium Cyanide | 1 | 2013 | 2 | 0.110 |
Why?
| Thiophenes | 1 | 2014 | 38 | 0.110 |
Why?
| Forced Expiratory Volume | 1 | 2014 | 52 | 0.110 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2011 | 52 | 0.110 |
Why?
| Quality of Health Care | 1 | 2015 | 187 | 0.100 |
Why?
| Rural Population | 1 | 2018 | 577 | 0.100 |
Why?
| Genomics | 1 | 2015 | 268 | 0.100 |
Why?
| Follow-Up Studies | 6 | 2017 | 2279 | 0.100 |
Why?
| Referral and Consultation | 1 | 2015 | 292 | 0.100 |
Why?
| Software | 1 | 2015 | 280 | 0.100 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 216 | 0.100 |
Why?
| Colostomy | 1 | 2012 | 11 | 0.100 |
Why?
| Patient Advocacy | 1 | 2012 | 17 | 0.100 |
Why?
| Pediatric Nursing | 1 | 2012 | 16 | 0.100 |
Why?
| Prevalence | 1 | 2015 | 1006 | 0.100 |
Why?
| Administration, Intravenous | 1 | 2012 | 73 | 0.100 |
Why?
| Antibodies, Monoclonal | 1 | 2016 | 481 | 0.100 |
Why?
| Receptors, Purinergic P2Y12 | 1 | 2012 | 13 | 0.100 |
Why?
| Receptors, Purinergic P2 | 1 | 2012 | 26 | 0.090 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2011 | 13 | 0.090 |
Why?
| Narcolepsy | 1 | 2011 | 12 | 0.090 |
Why?
| Patient Compliance | 1 | 2013 | 230 | 0.090 |
Why?
| Disabled Children | 1 | 2012 | 62 | 0.090 |
Why?
| Severity of Illness Index | 4 | 2021 | 1026 | 0.090 |
Why?
| Respiratory Physiological Phenomena | 2 | 2019 | 12 | 0.090 |
Why?
| Cyanides | 1 | 2011 | 5 | 0.090 |
Why?
| Telemedicine | 1 | 2018 | 494 | 0.090 |
Why?
| Glyburide | 1 | 2011 | 5 | 0.090 |
Why?
| Receptors, Drug | 1 | 2011 | 4 | 0.090 |
Why?
| Biophysics | 1 | 2011 | 15 | 0.090 |
Why?
| Diazoxide | 1 | 2011 | 7 | 0.090 |
Why?
| KATP Channels | 1 | 2011 | 6 | 0.090 |
Why?
| Sweetening Agents | 1 | 2011 | 22 | 0.090 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2011 | 34 | 0.090 |
Why?
| Electric Stimulation | 1 | 2011 | 107 | 0.090 |
Why?
| Collagen | 2 | 2022 | 211 | 0.090 |
Why?
| Ataxia Telangiectasia | 1 | 2010 | 6 | 0.090 |
Why?
| Apoptosis | 1 | 2016 | 1119 | 0.090 |
Why?
| Bronchiectasis | 1 | 2010 | 8 | 0.090 |
Why?
| Postoperative Complications | 4 | 2021 | 1068 | 0.090 |
Why?
| Vasodilator Agents | 1 | 2011 | 96 | 0.090 |
Why?
| Rubinstein-Taybi Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
| Electromyography | 2 | 2021 | 127 | 0.090 |
Why?
| Lung Diseases, Interstitial | 1 | 2010 | 25 | 0.080 |
Why?
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 3 | 0.080 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 35 | 0.080 |
Why?
| Carbon Dioxide | 1 | 2010 | 97 | 0.080 |
Why?
| Blood Pressure | 3 | 2005 | 537 | 0.080 |
Why?
| Arkansas | 1 | 2016 | 2028 | 0.080 |
Why?
| Deglutition Disorders | 2 | 2010 | 79 | 0.080 |
Why?
| Bronchodilator Agents | 1 | 2010 | 77 | 0.080 |
Why?
| Glossopharyngeal Nerve | 1 | 2009 | 2 | 0.080 |
Why?
| Potassium Chloride | 1 | 2009 | 19 | 0.080 |
Why?
| Ruthenium Red | 1 | 2009 | 5 | 0.080 |
Why?
| Gene Silencing | 1 | 2009 | 118 | 0.080 |
Why?
| Isomerism | 1 | 2009 | 24 | 0.080 |
Why?
| Potassium Channel Blockers | 1 | 2009 | 16 | 0.080 |
Why?
| Arachidonic Acids | 1 | 2009 | 22 | 0.080 |
Why?
| Magnesium | 1 | 2009 | 31 | 0.080 |
Why?
| Hypoglycemic Agents | 1 | 2011 | 211 | 0.080 |
Why?
| Coloring Agents | 1 | 2009 | 69 | 0.080 |
Why?
| Glucose | 1 | 2011 | 355 | 0.080 |
Why?
| Crohn Disease | 1 | 2010 | 117 | 0.080 |
Why?
| Prognosis | 3 | 2021 | 2099 | 0.080 |
Why?
| Adult | 5 | 2018 | 14161 | 0.080 |
Why?
| HeLa Cells | 1 | 2009 | 265 | 0.070 |
Why?
| Lung | 2 | 2022 | 509 | 0.070 |
Why?
| Carrier Proteins | 1 | 2009 | 313 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2018 | 595 | 0.070 |
Why?
| Propensity Score | 2 | 2019 | 154 | 0.070 |
Why?
| Fibrinolytic Agents | 2 | 2018 | 128 | 0.070 |
Why?
| Gene Expression Regulation | 1 | 2012 | 990 | 0.070 |
Why?
| Incidence | 3 | 2015 | 1062 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2015 | 1046 | 0.060 |
Why?
| Algorithms | 2 | 2024 | 672 | 0.060 |
Why?
| Intensive Care Units | 2 | 2020 | 243 | 0.060 |
Why?
| Blastomeres | 1 | 2025 | 2 | 0.060 |
Why?
| Mitochondrial Dynamics | 1 | 2025 | 23 | 0.060 |
Why?
| Rotenone | 1 | 2025 | 15 | 0.060 |
Why?
| Quinpirole | 1 | 2005 | 2 | 0.060 |
Why?
| Sulpiride | 1 | 2005 | 3 | 0.060 |
Why?
| Ubiquinone | 1 | 2025 | 14 | 0.060 |
Why?
| Mountaineering | 1 | 2005 | 2 | 0.060 |
Why?
| Dopamine Agonists | 1 | 2005 | 10 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2005 | 22 | 0.060 |
Why?
| Acclimatization | 1 | 2005 | 23 | 0.060 |
Why?
| Medulla Oblongata | 2 | 1995 | 20 | 0.060 |
Why?
| Isoenzymes | 1 | 2025 | 166 | 0.060 |
Why?
| Fetal Diseases | 1 | 2005 | 61 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2025 | 169 | 0.060 |
Why?
| Metformin | 1 | 2025 | 76 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2005 | 198 | 0.050 |
Why?
| Ventricular Dysfunction, Left | 1 | 2005 | 108 | 0.050 |
Why?
| Survival Rate | 2 | 2017 | 945 | 0.050 |
Why?
| Medical History Taking | 1 | 2004 | 47 | 0.050 |
Why?
| Circadian Rhythm | 1 | 2004 | 91 | 0.050 |
Why?
| DNA End-Joining Repair | 1 | 2023 | 15 | 0.050 |
Why?
| Snoring | 1 | 2003 | 9 | 0.050 |
Why?
| Catheters | 1 | 2023 | 36 | 0.050 |
Why?
| Gene Expression | 1 | 2006 | 618 | 0.050 |
Why?
| Mammals | 1 | 2023 | 61 | 0.050 |
Why?
| Etoposide | 1 | 2023 | 74 | 0.050 |
Why?
| Physical Examination | 1 | 2004 | 99 | 0.050 |
Why?
| Genes, Developmental | 1 | 2022 | 1 | 0.050 |
Why?
| Reflex | 1 | 2003 | 29 | 0.050 |
Why?
| Receptors, Dopamine D1 | 1 | 2003 | 7 | 0.050 |
Why?
| International Cooperation | 1 | 2003 | 49 | 0.050 |
Why?
| Nervous System | 1 | 2003 | 32 | 0.050 |
Why?
| X-Ray Microtomography | 1 | 2022 | 79 | 0.050 |
Why?
| Intensive Care Units, Neonatal | 1 | 2024 | 135 | 0.050 |
Why?
| Hospitals | 1 | 2024 | 182 | 0.050 |
Why?
| Collagen Type V | 1 | 2022 | 4 | 0.050 |
Why?
| Gestational Age | 1 | 2024 | 417 | 0.050 |
Why?
| Haploinsufficiency | 1 | 2022 | 15 | 0.050 |
Why?
| Respiratory Function Tests | 2 | 2014 | 90 | 0.050 |
Why?
| DNA Repair | 1 | 2023 | 195 | 0.050 |
Why?
| Fetus | 1 | 2003 | 194 | 0.050 |
Why?
| Pharynx | 2 | 2015 | 31 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 196 | 0.050 |
Why?
| Reproducibility of Results | 2 | 2021 | 1229 | 0.040 |
Why?
| Health Care Surveys | 1 | 2021 | 177 | 0.040 |
Why?
| Ventilator Weaning | 1 | 2020 | 21 | 0.040 |
Why?
| Administration, Inhalation | 2 | 2011 | 120 | 0.040 |
Why?
| Syndrome | 1 | 2021 | 247 | 0.040 |
Why?
| Consensus | 1 | 2021 | 181 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2019 | 39 | 0.040 |
Why?
| Crystallography, X-Ray | 1 | 2019 | 156 | 0.040 |
Why?
| Protein Conformation | 1 | 2019 | 176 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 229 | 0.040 |
Why?
| Transcriptome | 1 | 2021 | 370 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2020 | 153 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2024 | 804 | 0.040 |
Why?
| Clinical Protocols | 1 | 2019 | 108 | 0.040 |
Why?
| Models, Econometric | 1 | 2018 | 13 | 0.040 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 122 | 0.040 |
Why?
| Models, Molecular | 1 | 2019 | 348 | 0.040 |
Why?
| Markov Chains | 1 | 2018 | 30 | 0.040 |
Why?
| Heart Valve Prosthesis | 1 | 2019 | 86 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2019 | 443 | 0.040 |
Why?
| Cause of Death | 1 | 2018 | 160 | 0.040 |
Why?
| Health Resources | 1 | 2018 | 77 | 0.030 |
Why?
| Prosthesis Design | 1 | 2018 | 256 | 0.030 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 192 | 0.030 |
Why?
| Community Health Services | 1 | 2018 | 103 | 0.030 |
Why?
| Histidine | 1 | 2017 | 15 | 0.030 |
Why?
| Hemorrhage | 1 | 2018 | 209 | 0.030 |
Why?
| Quality Assurance, Health Care | 1 | 2018 | 149 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2018 | 267 | 0.030 |
Why?
| Cysteine | 1 | 2017 | 49 | 0.030 |
Why?
| Models, Statistical | 1 | 2018 | 230 | 0.030 |
Why?
| Research Design | 1 | 2019 | 359 | 0.030 |
Why?
| Epitope Mapping | 1 | 2016 | 7 | 0.030 |
Why?
| Cytochromes c | 1 | 2016 | 29 | 0.030 |
Why?
| Societies | 1 | 2016 | 8 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2016 | 46 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 2016 | 95 | 0.030 |
Why?
| Recurrence | 1 | 2018 | 672 | 0.030 |
Why?
| Cytosol | 1 | 2016 | 80 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 721 | 0.030 |
Why?
| Molecular Dynamics Simulation | 1 | 2016 | 44 | 0.030 |
Why?
| Molecular Docking Simulation | 1 | 2016 | 88 | 0.030 |
Why?
| Protein Multimerization | 1 | 2016 | 56 | 0.030 |
Why?
| Anticoagulants | 1 | 2018 | 270 | 0.030 |
Why?
| Quality Improvement | 1 | 2018 | 226 | 0.030 |
Why?
| Anticonvulsants | 1 | 2017 | 134 | 0.030 |
Why?
| District of Columbia | 1 | 2015 | 22 | 0.030 |
Why?
| Arginine | 1 | 2017 | 182 | 0.030 |
Why?
| Young Adult | 2 | 2018 | 4329 | 0.030 |
Why?
| Palate | 1 | 2015 | 13 | 0.030 |
Why?
| Uvula | 1 | 2015 | 13 | 0.030 |
Why?
| Cinnamates | 1 | 2015 | 2 | 0.030 |
Why?
| Thiourea | 1 | 2015 | 7 | 0.030 |
Why?
| Bronchography | 1 | 2015 | 6 | 0.030 |
Why?
| Computing Methodologies | 1 | 2015 | 2 | 0.030 |
Why?
| Product Surveillance, Postmarketing | 1 | 2015 | 19 | 0.030 |
Why?
| Genetic Techniques | 1 | 2015 | 15 | 0.030 |
Why?
| Adenoidectomy | 1 | 2015 | 35 | 0.030 |
Why?
| Electroencephalography | 1 | 2017 | 312 | 0.030 |
Why?
| Bronchi | 1 | 2015 | 43 | 0.030 |
Why?
| Heart Failure | 2 | 2015 | 565 | 0.030 |
Why?
| Afferent Pathways | 1 | 1994 | 12 | 0.030 |
Why?
| Hypoxia, Brain | 1 | 1994 | 13 | 0.030 |
Why?
| Tonsillectomy | 1 | 2015 | 49 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2015 | 50 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 50 | 0.030 |
Why?
| Cough | 1 | 2015 | 55 | 0.030 |
Why?
| Linear Models | 1 | 2015 | 287 | 0.030 |
Why?
| Swine | 1 | 2016 | 428 | 0.030 |
Why?
| Heart Valve Diseases | 1 | 2015 | 53 | 0.030 |
Why?
| Balloon Occlusion | 1 | 2014 | 17 | 0.030 |
Why?
| Protein Binding | 1 | 2016 | 667 | 0.030 |
Why?
| Bronchoscopy | 1 | 2015 | 76 | 0.030 |
Why?
| Cardiovascular Agents | 1 | 2014 | 59 | 0.030 |
Why?
| Fibroblasts | 1 | 2016 | 355 | 0.030 |
Why?
| Phenotype | 1 | 2017 | 789 | 0.030 |
Why?
| Caregivers | 1 | 2016 | 240 | 0.030 |
Why?
| Staff Development | 1 | 2013 | 24 | 0.030 |
Why?
| Cell Differentiation | 1 | 2016 | 665 | 0.030 |
Why?
| Professional-Patient Relations | 1 | 2013 | 47 | 0.030 |
Why?
| Seizures | 1 | 2015 | 208 | 0.030 |
Why?
| Professional Role | 1 | 2013 | 78 | 0.030 |
Why?
| Patient Readmission | 1 | 2015 | 246 | 0.020 |
Why?
| Ambulatory Care Facilities | 1 | 2013 | 124 | 0.020 |
Why?
| Internet | 1 | 2015 | 263 | 0.020 |
Why?
| Social Isolation | 1 | 2012 | 28 | 0.020 |
Why?
| Professional-Family Relations | 1 | 2012 | 44 | 0.020 |
Why?
| Quality of Life | 1 | 2018 | 879 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2015 | 979 | 0.020 |
Why?
| Sleep, REM | 1 | 2011 | 44 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 137 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 174 | 0.020 |
Why?
| Ambulatory Care | 1 | 2013 | 239 | 0.020 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2011 | 6 | 0.020 |
Why?
| Middle Aged | 2 | 2018 | 13028 | 0.020 |
Why?
| Potassium Channels | 1 | 2011 | 32 | 0.020 |
Why?
| Calcium Signaling | 1 | 2011 | 51 | 0.020 |
Why?
| Schools | 1 | 2012 | 172 | 0.020 |
Why?
| Emotions | 1 | 2012 | 174 | 0.020 |
Why?
| Social Support | 1 | 2012 | 268 | 0.020 |
Why?
| Stress, Psychological | 1 | 2012 | 273 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2013 | 321 | 0.020 |
Why?
| Comorbidity | 1 | 2011 | 625 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2017 | 1546 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2015 | 1165 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 261 | 0.020 |
Why?
| Gene Deletion | 1 | 2010 | 272 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1201 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 467 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2010 | 488 | 0.020 |
Why?
| Barium Sulfate | 1 | 2006 | 11 | 0.020 |
Why?
| Respiratory Aspiration | 1 | 2006 | 9 | 0.020 |
Why?
| Fluoroscopy | 1 | 2006 | 50 | 0.020 |
Why?
| Video Recording | 1 | 2006 | 81 | 0.020 |
Why?
| Cardiac Volume | 1 | 2005 | 6 | 0.010 |
Why?
| Contrast Media | 1 | 2006 | 193 | 0.010 |
Why?
| Diastole | 1 | 2005 | 70 | 0.010 |
Why?
| Carotid Sinus | 2 | 1995 | 5 | 0.010 |
Why?
| Denervation | 2 | 1995 | 19 | 0.010 |
Why?
| Systole | 1 | 2005 | 72 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2005 | 95 | 0.010 |
Why?
| Cats | 2 | 1995 | 73 | 0.010 |
Why?
| Myocardial Contraction | 1 | 2005 | 112 | 0.010 |
Why?
| Oxyhemoglobins | 1 | 2004 | 5 | 0.010 |
Why?
| Blood Gas Analysis | 1 | 2004 | 29 | 0.010 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 34 | 0.010 |
Why?
| Ventricular Function, Left | 1 | 2005 | 172 | 0.010 |
Why?
| Arousal | 1 | 2004 | 101 | 0.010 |
Why?
| Ganglia, Sensory | 1 | 2003 | 1 | 0.010 |
Why?
| Superior Cervical Ganglion | 1 | 2003 | 7 | 0.010 |
Why?
| Corpus Striatum | 1 | 2003 | 49 | 0.010 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 77 | 0.010 |
Why?
| International Classification of Diseases | 1 | 2003 | 67 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2003 | 374 | 0.010 |
Why?
| Rabbits | 1 | 2003 | 375 | 0.010 |
Why?
| Echocardiography | 1 | 2005 | 415 | 0.010 |
Why?
| Body Mass Index | 1 | 2004 | 689 | 0.010 |
Why?
| Vagotomy | 1 | 1995 | 4 | 0.010 |
Why?
| Nitroprusside | 1 | 1995 | 11 | 0.010 |
Why?
| Phenylephrine | 1 | 1995 | 34 | 0.010 |
Why?
| Optics and Photonics | 1 | 1995 | 10 | 0.010 |
Why?
| Light | 1 | 1995 | 73 | 0.010 |
Why?
| Tidal Volume | 1 | 1994 | 60 | 0.010 |
Why?
| Cerebral Cortex | 1 | 1995 | 198 | 0.010 |
Why?
| Electrocardiography | 1 | 1994 | 268 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|